Home/Filings/4/0001415889-25-006686
4//SEC Filing

Hanley David C. 4

Accession 0001415889-25-006686

CIK 0001811063other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:29 PM ET

Size

6.5 KB

Accession

0001415889-25-006686

Insider Transaction Report

Form 4
Period: 2025-02-28
Hanley David C.
CHIEF TECHNICAL OPERATIONS
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-28+500,000500,000 total
    Exercise: $1.97Exp: 2035-02-27Class A Common Stock (500,000 underlying)
Holdings
  • Class A Common Stock

    18,000
Footnotes (2)
  • [F1]Includes 3,000 shares acquired on May 17, 2024 and 3,000 shares acquired on November 19, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.
  • [F2]Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

Issuer

Nuvation Bio Inc.

CIK 0001811063

Entity typeother

Related Parties

1
  • filerCIK 0001865826

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:29 PM ET
Size
6.5 KB